<DOC>
	<DOCNO>NCT00756080</DOCNO>
	<brief_summary>The specific aim study determine whether oral citrulline administration enhance whole body protein synthesis healthy human postabsorptive state . Protein metabolism assess use intravenous infusion stable isotope label leucine . The investigator hypothesize citrulline supplementation decrease leucine oxidation without alter proteolysis , consequently stimulate protein synthesis .</brief_summary>
	<brief_title>`` Effects Oral Citrulline Protein Metabolism Healthy Humans : Prospective , Randomized , Double-blind , Cross-over Study '' ( Citrugrêle )</brief_title>
	<detailed_description />
	<criteria>Healthy adult 18 45 year age Absence early supplementation citrulline , glutamine , ornithine aketoglutarate , stimol® Absence treatment anabolic agent month prior inclusion study No current artificial feeding ( enteral parenteral ) No renal , cardiac , respiratory hepatic insufficiency No chronic inflammatory disease ( intestinal No current corticotherapy Fasting blood glucose 6mmol/L ( 126 mg/dL ) Body mass index 19 24.9 Patient able understand benefit risk protocol Not pregnant , take oral contraceptive measure able procreate Subject affiliate French health insurance ( Sécurité Sociale ) Informed consent form sign No concomitant participation another clinical trial , compliance exclusion period require law Subject fulfil inclusion criterion Subject mention article L11215 L11218 `` code de la santé publique '' Subject participation clinical trial would result , cumulate stipend receive clinical trial , earn 4500 € within 12 consecutive month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>